$UTHR
UNITED THERAPEUTICS Corp Stock $uthr

$uthr Overview Financials Valuation SEC Filings Company Website

2019 Q4 Form 10-K Financial Statement

#000110465920025009 Filed on February 26, 2020

Income Statement

Concept	2019 Q4	2019 Q3	2019 Q2
Revenue	$311.1M	$401.5M	$373.6M
YoY Change	-18.43%	-2.71%	-15.95%
Cost Of Revenue	$28.80M	$33.00M	$26.70M
YoY Change	-9.72%	-36.42%	-56.73%
Gross Profit	$282.3M	$368.5M	$346.9M
YoY Change	-19.23%	2.13%	-9.38%
Gross Profit Margin	90.74%	91.78%	92.85%
Selling, General & Admin	$105.2M	$99.40M	$39.60M
YoY Change	32.83%	-9.72%	-52.35%
% of Gross Profit	37.27%	26.97%	11.42%
Research & Development	$113.6M	$85.70M	$85.90M
YoY Change	-18.16%	-15.23%	4.37%
% of Gross Profit	40.24%	23.26%	24.76%
Depreciation & Amortization	$12.50M	$12.70M	$10.40M
YoY Change	19.05%	35.11%	28.4%
% of Gross Profit	4.43%	3.45%	3.0%
Operating Expenses	$218.8M	$85.70M	$85.90M
YoY Change	0.37%	-15.23%	4.37%
Operating Profit	$63.50M	$183.4M	$221.4M
YoY Change	-51.71%	22.59%	1.84%
Interest Expense	$3.400M	$11.70M	$12.20M
YoY Change	-22.73%	185.37%	320.69%
% of Operating Profit	5.35%	6.38%	5.51%
Other Income/Expense, Net	$1.400M	-$16.50M	$29.00M
YoY Change	-148.28%	73.68%	5700.0%
Pretax Income	$68.30M	$166.9M	$250.4M
YoY Change	-25.68%	19.13%	14.92%
Income Tax	$15.70M	$34.50M	$45.30M
% Of Pretax Income	22.99%	20.67%	18.09%
Net Earnings	$52.60M	$132.4M	$205.1M
YoY Change	-19.45%	24.32%	18.62%
Net Earnings / Revenue	16.91%	32.98%	54.9%
Basic Earnings Per Share	$1.20	$3.02	$4.68
Diluted Earnings Per Share	$1.20	$3.01	$4.66
COMMON SHARES
Basic Shares Outstanding	43.88M	43.90M shares	43.80M shares
Diluted Shares Outstanding		44.00M shares	44.00M shares

Balance Sheet

Concept	2019 Q4	2019 Q3	2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.486B	$1.570B	$1.786B
YoY Change	4.94%	26.86%	47.25%
Cash & Equivalents	$738.4M	$719.7M	$881.3M
Short-Term Investments	$747.5M	$850.3M	$904.9M
Other Short-Term Assets	$133.8M	$85.70M	$75.70M
YoY Change	77.45%	56.1%	32.34%
Inventory	$93.40M	$94.10M	$96.90M
Prepaid Expenses
Receivables	$151.4M	$183.6M	$181.0M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$1.865B	$1.933B	$2.140B
YoY Change	5.46%	20.18%	31.74%
LONG-TERM ASSETS
Property, Plant & Equipment	$738.5M	$678.3M	$709.3M
YoY Change	5.55%	1.97%	13.29%
Goodwill	$28.00M	$28.00M	$31.50M
YoY Change	-11.11%
Intangibles
YoY Change
Long-Term Investments	$767.5M	$730.4M	$420.7M
YoY Change	73.41%	22.57%	-27.25%
Other Assets	$154.6M	$231.0M	$202.9M
YoY Change	-31.04%	-38.33%	-45.27%
Total Long-Term Assets	$2.049B	$2.066B	$1.759B
YoY Change	25.47%	14.57%	8.54%
TOTAL ASSETS
Total Short-Term Assets	$1.865B	$1.933B	$2.140B
Total Long-Term Assets	$2.049B	$2.066B	$1.759B
Total Assets	$3.913B	$4.000B	$3.899B
YoY Change	15.07%	17.22%	20.15%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$9.900M	$161.1M	$163.9M
YoY Change	-57.14%	-21.34%	-24.12%
Accrued Expenses	$138.5M	$1.900M	$2.900M
YoY Change	-3.15%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$250.0M	$250.0M	$250.0M
YoY Change
Total Short-Term Liabilities	$463.0M	$469.9M	$463.5M
YoY Change	67.39%	26.18%	32.43%
LONG-TERM LIABILITIES
Long-Term Debt	$600.0M	$750.0M	$800.0M
YoY Change	140.0%	200.0%	220.0%
Other Long-Term Liabilities	$70.00M	$63.90M	$68.60M
YoY Change	5.11%	-17.76%	14.14%
Total Long-Term Liabilities	$70.00M	$63.90M	$68.60M
YoY Change	5.11%	-80.5%	-77.88%
TOTAL LIABILITIES
Total Short-Term Liabilities	$463.0M	$469.9M	$463.5M
Total Long-Term Liabilities	$70.00M	$63.90M	$68.60M
Total Liabilities	$1.133B	$1.284B	$1.332B
YoY Change	91.0%	83.37%	101.8%
SHAREHOLDERS EQUITY
Retained Earnings	$3.325B	$3.273B	$3.140B
YoY Change	-3.19%
Common Stock	$2.049B	$2.027B	$2.002B
YoY Change	5.55%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.780B	$2.716B	$2.558B
YoY Change
Total Liabilities & Shareholders Equity	$3.913B	$4.000B	$3.899B
YoY Change	15.07%	17.22%	20.15%

Cashflow Statement

Concept	2019 Q4	2019 Q3	2019 Q2
OPERATING ACTIVITIES
Net Income	$52.60M	$132.4M	$205.1M
YoY Change	-19.45%	24.32%	18.62%
Depreciation, Depletion And Amortization	$12.50M	$12.70M	$10.40M
YoY Change	19.05%	35.11%	28.4%
Cash From Operating Activities	$102.5M	$185.4M	$132.9M
YoY Change	20.02%	-21.94%	-26.08%
INVESTING ACTIVITIES
Capital Expenditures	-$24.70M	-$13.60M	-$20.30M
YoY Change	-52.32%	-67.23%	-62.06%
Acquisitions
YoY Change
Other Investing Activities	$90.90M	-$285.1M	-$22.30M
YoY Change	-545.59%	-1.14%	-92.72%
Cash From Investing Activities	$66.20M	-$298.7M	-$42.60M
YoY Change	-191.69%	-9.46%	-88.16%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-150.0M	-48.30M	400.0K
YoY Change	-150100.0%	-2112.5%	-105.88%
NET CHANGE
Cash From Operating Activities	102.5M	185.4M	132.9M
Cash From Investing Activities	66.20M	-298.7M	-42.60M
Cash From Financing Activities	-150.0M	-48.30M	400.0K
Net Change In Cash	18.70M	-161.6M	90.70M
YoY Change	40.6%	79.56%	-148.55%
FREE CASH FLOW
Cash From Operating Activities	$102.5M	$185.4M	$132.9M
Capital Expenditures	-$24.70M	-$13.60M	-$20.30M
Free Cash Flow	$127.2M	$199.0M	$153.2M
YoY Change	-7.29%	-28.67%	-34.33%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2008Q2	uthr	Class Of Warrant Or Right Shares Of Series A Junior Participating Preferred Stock Per Right ClassOfWarrantOrRightSharesOfSeriesAJuniorParticipatingPreferredStockPerRight	0.001
CY2019	uthr	Defined Contribution Plan Annual Increments DefinedContributionPlanAnnualIncrements	0.33
CY2018Q4	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	0
CY2019Q4	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	0
CY2019	dei	Entity Central Index Key EntityCentralIndexKey	0001082554
CY2019	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2019	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
CY2019	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2019	dei	Amendment Flag AmendmentFlag	false
CY2019Q1	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	us-gaap:OtherAssetsNoncurrent
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	us-gaap:OtherAssetsNoncurrent
CY2019Q1	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	us-gaap:OtherLiabilitiesCurrent
CY2019Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	us-gaap:OtherLiabilitiesCurrent
CY2019Q1	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	us-gaap:OtherLiabilitiesNoncurrent
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	us-gaap:OtherLiabilitiesNoncurrent
CY2019Q1	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	us-gaap:OperatingLeaseLiabilityCurrent us-gaap:OperatingLeaseLiabilityNoncurrent
CY2019Q4	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	us-gaap:OperatingLeaseLiabilityCurrent us-gaap:OperatingLeaseLiabilityNoncurrent
CY2019	dei	Document Type DocumentType	10-K
CY2019	dei	Document Annual Report DocumentAnnualReport	true
CY2019	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2019	dei	Entity Shell Company EntityShellCompany	false
CY2019Q2	dei	Entity Public Float EntityPublicFloat	2976670801
CY2019Q4	us-gaap	Inventory Net InventoryNet	93400000
CY2018Q4	us-gaap	Inventory Net InventoryNet	101000000.0
CY2019	dei	Document Period End Date DocumentPeriodEndDate	2019-12-31
CY2019	dei	Document Transition Report DocumentTransitionReport	false
CY2019	dei	Entity File Number EntityFileNumber	0-26301
CY2019	dei	Entity Registrant Name EntityRegistrantName	United Therapeutics Corporation
CY2019	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2019	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	52-1984749
CY2019	dei	Entity Address Address Line1 EntityAddressAddressLine1	1040 Spring Street
CY2019	dei	Entity Address City Or Town EntityAddressCityOrTown	Silver Spring
CY2019	dei	Entity Address State Or Province EntityAddressStateOrProvince	MD
CY2019	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	20910
CY2019	dei	City Area Code CityAreaCode	301
CY2019	dei	Local Phone Number LocalPhoneNumber	608-9292
CY2019	dei	Security12b Title Security12bTitle	Common Stock, par value $.01 per share
CY2019	dei	Trading Symbol TradingSymbol	UTHR
CY2019	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2019	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2019	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2019	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2019	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2019	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2019	dei	Entity Small Business EntitySmallBusiness	false
CY2020Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	43884990
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	738400000
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	669200000
CY2019Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	747500000
CY2018Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	746700000
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	151400000
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	175700000
CY2019Q4	us-gaap	Other Assets Current OtherAssetsCurrent	133800000
CY2018Q4	us-gaap	Other Assets Current OtherAssetsCurrent	75400000
CY2019Q4	us-gaap	Assets Current AssetsCurrent	1864500000
CY2018Q4	us-gaap	Assets Current AssetsCurrent	1768000000.0
CY2019Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	767500000
CY2018Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	442600000
CY2019Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	158300000
CY2018Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	170800000
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	738500000
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	699700000
CY2019Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	230000000.0
CY2018Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	95700000
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	154600000
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	224200000
CY2019Q4	us-gaap	Assets Assets	3913400000
CY2018Q4	us-gaap	Assets Assets	3401000000.0
CY2019Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	148400000
CY2018Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	166100000
CY2019Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	250000000.0
CY2019Q4	uthr	Share Tracking Award Plans ShareTrackingAwardPlans	25000000.0
CY2018Q4	uthr	Share Tracking Award Plans ShareTrackingAwardPlans	72200000
CY2019Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	39600000
CY2018Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	38300000
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	463000000.0
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	276600000
CY2019Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	600000000.0
CY2018Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	250000000.0
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	70000000.0
CY2018Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	66600000
CY2019Q4	us-gaap	Liabilities Liabilities	1133000000.0
CY2018Q4	us-gaap	Liabilities Liabilities	593200000
CY2018Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	19200000
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	245000000
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	245000000
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	70503775
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	70207581
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	43884559
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	43588365
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	700000
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	700000
CY2019Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2047900000
CY2018Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1940200000
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-14200000
CY2018Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-7900000
CY2018Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	26619216
CY2019Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	26619216
CY2019Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	2579200000
CY2018Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	2579200000
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	3325200000
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	3434800000
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	2780400000
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	2788600000
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3913400000
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3401000000.0
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1448800000
CY2018	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1627800000
CY2017	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1725300000
CY2017	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	44000000.0
CY2019	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	117600000
CY2018	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	198700000
CY2017	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	105700000
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1182600000
CY2018	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	357900000
CY2017	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	264600000
CY2019	uthr	Selling General And Administrative Expense And Adjustments SellingGeneralAndAdministrativeExpenseAndAdjustments	336200000
CY2018	uthr	Selling General And Administrative Expense And Adjustments SellingGeneralAndAdministrativeExpenseAndAdjustments	265800000
CY2017	uthr	Selling General And Administrative Expense And Adjustments SellingGeneralAndAdministrativeExpenseAndAdjustments	330100000
CY2017	us-gaap	Loss Contingency Loss In Period LossContingencyLossInPeriod	210000000.0
CY2019	us-gaap	Costs And Expenses CostsAndExpenses	1636400000
CY2018	us-gaap	Costs And Expenses CostsAndExpenses	822400000
CY2017	us-gaap	Costs And Expenses CostsAndExpenses	910400000
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-187600000
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	805400000
CY2017	us-gaap	Operating Income Loss OperatingIncomeLoss	814900000
CY2019	us-gaap	Investment Income Interest InvestmentIncomeInterest	44200000
CY2018	us-gaap	Investment Income Interest InvestmentIncomeInterest	28600000
CY2017	us-gaap	Investment Income Interest InvestmentIncomeInterest	10900000
CY2019	us-gaap	Interest Expense InterestExpense	44200000
CY2018	us-gaap	Interest Expense InterestExpense	13900000
CY2017	us-gaap	Interest Expense InterestExpense	9000000.0
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	22600000
CY2018	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-7700000
CY2017	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2300000
CY2018	uthr	Impairment Of Investments In Privately Held Companies ImpairmentOfInvestmentsInPrivatelyHeldCompanies	53500000
CY2017	uthr	Impairment Of Investments In Privately Held Companies ImpairmentOfInvestmentsInPrivatelyHeldCompanies	49600000
CY2019	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	22600000
CY2018	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-46500000
CY2017	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-45400000
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-165000000.0
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	758900000
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	769500000
CY2017	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	1100000
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-60500000
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	169700000
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	351600000
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-104500000
CY2018	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	589200000
CY2017	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	417900000
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.39
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	13.54
CY2017	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	9.50
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.39
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	13.39
CY2017	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	9.31
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43800000
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43500000
CY2017	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	4100000
CY2017	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	250000000.0
CY2019	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	12300000
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43800000
CY2018	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	44000000.0
CY2017	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	44900000
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-104500000
CY2018	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	589200000
CY2017	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	417900000
CY2017	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	200000
CY2019	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	-10600000
CY2018	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	10700000
CY2017	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	-1700000
CY2019	uthr	Other Comprehensive Income Loss Amortization Gain Loss And Net Prior Service Costs Credit Arising During Period Net Of Tax OtherComprehensiveIncomeLossAmortizationGainLossAndNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax	-1700000
CY2018	uthr	Other Comprehensive Income Loss Amortization Gain Loss And Net Prior Service Costs Credit Arising During Period Net Of Tax OtherComprehensiveIncomeLossAmortizationGainLossAndNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax	1400000
CY2017	uthr	Other Comprehensive Income Loss Amortization Gain Loss And Net Prior Service Costs Credit Arising During Period Net Of Tax OtherComprehensiveIncomeLossAmortizationGainLossAndNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax	600000
CY2019	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	12300000
CY2018	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	-12100000
CY2017	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	1100000
CY2019	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	6000000.0
CY2018	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-400000
CY2017	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-1900000
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-6300000
CY2018	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	11700000
CY2017	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-2800000
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-110800000
CY2018	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	600900000
CY2017	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	415100000
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	1851300000
CY2017	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	417900000
CY2017	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	200000
CY2017	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-1900000
CY2017	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	39900000
CY2017	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	46400000
CY2017	us-gaap	Cumulative Effect On Retained Earnings Net Of Tax1 CumulativeEffectOnRetainedEarningsNetOfTax1	-5100000
CY2017	us-gaap	Variable Interest Entity Initial Consolidation Gain Or Loss VariableInterestEntityInitialConsolidationGainOrLoss	100000
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	2101800000
CY2018	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	589200000
CY2018	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-400000
CY2018	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	-12100000
CY2018	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	3900000
CY2018	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	100000
CY2018	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	15600000
CY2018	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	66500000
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	2788600000
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-104500000
CY2019	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	6000000.0
CY2019	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	4100000
CY2017	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	19400000
CY2019	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-16300000
CY2018	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-11000000.0
CY2019	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	2100000
CY2019	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	9900000
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	85100000
CY2019	us-gaap	Cumulative Effect On Retained Earnings Net Of Tax1 CumulativeEffectOnRetainedEarningsNetOfTax1	-5100000
CY2019	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	10800000
CY2019	uthr	Deconsolidation Of Variable Interest Entity DeconsolidationOfVariableInterestEntity	-100000
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	2780400000
CY2019Q2	uthr	Temporary Equity Amount Of Common Stock Subject To Repurchase TemporaryEquityAmountOfCommonStockSubjectToRepurchase	10800000
CY2019	us-gaap	Profit Loss ProfitLoss	-104500000
CY2018	us-gaap	Profit Loss ProfitLoss	589200000
CY2017	us-gaap	Profit Loss ProfitLoss	417900000
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	45900000
CY2018	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	35900000
CY2017	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	31000000.0
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	45400000
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	-26400000
CY2017	us-gaap	Share Based Compensation ShareBasedCompensation	73500000
CY2018	uthr	Impairment Of Investments In Privately Held Companies ImpairmentOfInvestmentsInPrivatelyHeldCompanies	53500000
CY2017	uthr	Impairment Of Investments In Privately Held Companies ImpairmentOfInvestmentsInPrivatelyHeldCompanies	49600000
CY2019	us-gaap	Asset Impairment Charges AssetImpairmentCharges	17200000
CY2019	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	29700000
CY2018	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-1800000
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-24400000
CY2018	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-121400000
CY2017	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	82700000
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-12900000
CY2018	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-9300000
CY2017	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	500000
CY2017	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	66200000
CY2019	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	201900000
CY2018	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-4700000
CY2017	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	61400000
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-206600000
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	778400000
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	474200000
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	83700000
CY2018	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	184400000
CY2017	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	86300000
CY2017	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	8300000
CY2018	uthr	Advance Payment Related To Property Plant And Equipment AdvancePaymentRelatedToPropertyPlantAndEquipment	46000000.0
CY2018	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	99300000
CY2017	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	51800000
CY2019	us-gaap	Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities	39700000
CY2018	us-gaap	Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities	88600000
CY2017	us-gaap	Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities	52900000
CY2019	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	1271500000
CY2018	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	762700000
CY2017	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	718400000
CY2019	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	980100000
CY2018	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	312300000
CY2017	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	20000000.0
CY2019	us-gaap	Proceeds From Sale Of Trading Securities Heldforinvestment ProceedsFromSaleOfTradingSecuritiesHeldforinvestment	20500000
CY2019	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	8000000.0
CY2018	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	5000000.0
CY2017	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	60400000
CY2019	uthr	Decrease In Cash Due To Deconsolidation Of Variable Interest Entity DecreaseInCashDueToDeconsolidationOfVariableInterestEntity	12500000
CY2017	uthr	Payments To Acquire Variable Interest Entity PaymentsToAcquireVariableInterestEntity	-100000
CY2018	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	124100000
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-335400000
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-820600000
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-835600000
CY2019	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	800000000.0
CY2018	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	250000000.0
CY2017	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	250000000.0
CY2019	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	200000000.0
CY2018	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	250000000.0
CY2019	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	700000
CY2018	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	13200000
CY2017	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	700000
CY2017	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	250000000.0
CY2019	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	9900000
CY2018	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	15600000
CY2017	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	39900000
CY2019	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	4100000
CY2018	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	3900000
CY2017	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	4100000
CY2019	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2100000
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	611200000
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6300000
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	43300000
CY2017	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	200000
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	69200000
CY2018	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-35900000
CY2017	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-317900000
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	669200000
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	705100000
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1023000000.0
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	738400000
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	669200000
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	705100000
CY2019	us-gaap	Interest Paid Net InterestPaidNet	41000000.0
CY2018	us-gaap	Interest Paid Net InterestPaidNet	9400000
CY2017	us-gaap	Interest Paid Net InterestPaidNet	7500000
CY2019	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	120200000
CY2018	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	102700000
CY2017	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	346900000
CY2017	us-gaap	Loss Contingency Loss In Period LossContingencyLossInPeriod	210000000.0
CY2019	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	54500000
CY2018	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	11500000
CY2017	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	11500000
CY2019	us-gaap	Nature Of Operations NatureOfOperations	<p style="font-family:'Times New Roman';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 6pt 0pt;">1. Organization and Business Description</p><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;text-indent:18pt;margin:0pt 0pt 6pt 0pt;">United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of innovative products to address the unmet medical needs of patients with chronic and life-threatening conditions.</p><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;text-indent:18pt;margin:0pt 0pt 6pt 0pt;">We have approval from the U.S. Food and Drug Administration (FDA) to market the following therapies: Remodulin<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">®</sup> (treprostinil) Injection (Remodulin), Tyvaso<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">®</sup> (treprostinil) Inhalation Solution (Tyvaso), Orenitram<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">®</sup> (treprostinil) Extended-Release Tablets (Orenitram), Unituxin<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">®</sup> (dinutuximab) Injection (Unituxin) and Adcirca<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">®</sup> (tadalafil) Tablets (Adcirca). Our only significant revenues outside the United States are derived from sales of Remodulin in Europe.</p><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As used in these notes to our consolidated financial statements, unless the context otherwise requires, the terms “we”, “us”, “our”, and similar terms refer to United Therapeutics Corporation and its consolidated subsidiaries.</p>
CY2019	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:12pt 0pt 6pt 18pt;">Use of Estimates</p><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The preparation of our consolidated financial statements in accordance with GAAP requires our management to make estimates and assumptions that affect reported amounts of assets and liabilities at the date of our consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. We base our estimates on assumptions regarding historical experience, currently available information and anticipated developments that we believe are reasonable and appropriate. However, because the use of estimates involves an inherent degree of uncertainty, actual results could differ from those estimates. Estimates are used for, but not limited to, revenue recognition, share-based compensation, determining the fair value of assets acquired and liabilities assumed in business combinations, marketable investments, fair value measurements (including those related to contingent consideration), inventory reserves, investments in privately-held companies, income taxes, goodwill and other intangible assets, and obligations related to our Supplemental Executive Retirement Plan.</p>
CY2018Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	5100000
CY2018Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	170800000
CY2019Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	21100000
CY2018Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	24300000
CY2019Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	29100000
CY2018Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	28000000.0
CY2019Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	43200000
CY2018Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	48700000
CY2019Q4	us-gaap	Inventory Net InventoryNet	93400000
CY2018Q4	us-gaap	Inventory Net InventoryNet	101000000.0
CY2019	uthr	Goodwill Wrote Off Upon Deconsolidation Of Variable Interest Entity GoodwillWroteOffUponDeconsolidationOfVariableInterestEntity	3500000
CY2018	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2018	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0
CY2019	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0
CY2019Q4	us-gaap	Goodwill Gross GoodwillGross	28000000.0
CY2019Q4	us-gaap	Goodwill Goodwill	28000000.0
CY2018Q4	us-gaap	Goodwill Gross GoodwillGross	31500000
CY2018Q4	us-gaap	Goodwill Goodwill	31500000
CY2019Q4	uthr	Goodwill And Other Intangibles Assets Gross GoodwillAndOtherIntangiblesAssetsGross	163600000
CY2019Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	5300000
CY2019Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	158300000
CY2018Q4	uthr	Goodwill And Other Intangibles Assets Gross GoodwillAndOtherIntangiblesAssetsGross	175900000
CY2019Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	200000
CY2019Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	1452000000.0
CY2019Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	1452000000.0
CY2019Q3	uthr	Goodwill Wrote Off Upon Deconsolidation Of Variable Interest Entity GoodwillWroteOffUponDeconsolidationOfVariableInterestEntity	3500000
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	200000
CY2018	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	100000
CY2017	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	500000
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1007900000
CY2018Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	934300000
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	269400000
CY2018Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	234600000
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	738500000
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	699700000
CY2019	us-gaap	Depreciation Depreciation	45700000
CY2018	us-gaap	Depreciation Depreciation	35800000
CY2017	us-gaap	Depreciation Depreciation	30500000
CY2019	uthr	Reclassification From Property Plant And Equipment To Other Noncurrent Assets ReclassificationFromPropertyPlantAndEquipmentToOtherNoncurrentAssets	23700000
CY2019	uthr	Number Of Disclosed Commercially Approved Products NumberOfDisclosedCommerciallyApprovedProducts	5
CY2019	uthr	Decrease In Net Sales Revenue DecreaseInNetSalesRevenue	2300000
CY2018	uthr	Increase In Net Product Sales IncreaseInNetProductSales	8800000
CY2018Q4	uthr	Reversal Of Estimated Liability Rebates ReversalOfEstimatedLiabilityRebates	13600000
CY2019	uthr	Rebates And Chargebacks Maximum Eligible Payment Period RebatesAndChargebacksMaximumEligiblePaymentPeriod	P6M
CY2019Q4	uthr	Accrued Rebates And Chargebacks AccruedRebatesAndChargebacks	51700000
CY2018Q4	uthr	Accrued Rebates And Chargebacks AccruedRebatesAndChargebacks	54700000
CY2019	uthr	Revenue Deduction Rebates And Chargebacks RevenueDeductionRebatesAndChargebacks	178700000
CY2018	uthr	Revenue Deduction Rebates And Chargebacks RevenueDeductionRebatesAndChargebacks	223700000
CY2017	uthr	Revenue Deduction Rebates And Chargebacks RevenueDeductionRebatesAndChargebacks	241500000
CY2019	uthr	Prompt Pay Discount Maximum Eligible Payment Period PromptPayDiscountMaximumEligiblePaymentPeriod	P30D
CY2019	uthr	Expiration Period For Right To Return Product ExpirationPeriodForRightToReturnProduct	P12M
CY2019	uthr	Allowance For Product Returns AllowanceForProductReturns	-6200000
CY2018	uthr	Allowance For Product Returns AllowanceForProductReturns	17500000
CY2017	uthr	Allowance For Product Returns AllowanceForProductReturns	900000
CY2018Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	1149700000
CY2019Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	1447600000
CY2019	us-gaap	Description Of New Accounting Pronouncements Not Yet Adopted DescriptionOfNewAccountingPronouncementsNotYetAdopted	<p style="font-family:'Times New Roman';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 6pt 0pt;">3. Recently Issued Accounting Standards</p><p style="font-family:'Times New Roman';font-size:10pt;font-style:italic;line-height:1.19;margin:6pt 0pt 6pt 18pt;">Accounting Standards Adopted</p><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;text-indent:18pt;margin:0pt 0pt 6pt 0pt;">In February 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2016-02, <i style="font-style:italic;">Leases</i> (Topic 842) (ASU 2016-02), which requires that assets and liabilities arising under leases be recognized on the balance sheets. ASU 2016-02 also requires additional quantitative and qualitative disclosures of the amount, timing and uncertainty of cash flows relating to lease arrangements. ASU 2016-02 was effective for annual reporting periods beginning after December 15, 2018. In July 2018, the FASB issued ASU No. 2018-11, <i style="font-style:italic;">Leases (Topic 842)—Targeted Improvements</i> (ASU 2018-11). ASU 2018-11 allows entities to elect a simplified transition method, allowing for application of ASU 2016-02 at the adoption date, with recognition of a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption. We adopted this standard on January 1, 2019 using the simplified transition method, allowing us to not restate comparative periods and apply ASC 842 on a prospective basis, resulting in a balance sheet presentation that, in certain respects, is not comparable to the prior period in the first year of adoption. We elected the practical expedient package permitted under the transition guidance within the new standard, which among other things, allows us to carry forward historical lease classifications. We also elected to use the lessee component election, allowing us to account for the lease and non-lease components as a single lease component. As the majority of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments. We made an accounting policy election to keep leases with an initial term of 12 months or less off of our consolidated balance sheets. We recognize lease payments for such leases in our consolidated statements of operations on a straight-line basis over the lease term.</p><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;text-indent:18pt;margin:0pt 0pt 6pt 0pt;">Upon adoption of this standard, we recognized a right-of-use asset of $8.2 million, and a corresponding lease liability of the same amount, related to our operating leases as of January 1, 2019. In addition, we recognized a cumulative-effect adjustment for the de-recognition of our build-to-suit leases as these leases no longer qualify for build-to-suit accounting and have instead been recognized as operating leases under ASC 842. The adjustment resulted in a decrease to retained earnings of $5.1 million, which is net of a tax benefit. At adoption, our weighted average remaining lease term was <span style="white-space:pre-wrap;">3.0</span><span style="white-space:pre-wrap;"> years and our weighted-average discount rate was 4.9%.</span></p><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;text-indent:18pt;margin:0pt;">Supplemental balance sheet information related to operating leases was as follows (in millions):</p><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;margin:0pt;"><span style="font-size:6pt;visibility:hidden;"></span></p><table style="border-collapse:collapse;font-size:16pt;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:32.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:0pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:0pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:32.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:0pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:0pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:0pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:0pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:0pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:0pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:0pt;visibility:hidden;"></span></p></div></div></td></tr><tr><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:32.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri';font-size:8pt;margin-bottom:0pt;visibility:hidden;"></span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:32.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Financial Statement Line Item on our</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:13.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31,</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:13.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;">January 1, </b></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:32.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Operating Leases</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:0pt;visibility:hidden;"></span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:32.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Consolidated Balance Sheets</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:0pt;visibility:hidden;"></span></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:13.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:0pt;visibility:hidden;"></span></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:13.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:32.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Right-of-use assets</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:32.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Tc_ETzPq41cQkWny2lKfRG5NA_3_2"><span style="-sec-ix-hidden:Tc_ETzPq41cQkWny2lKfRG5NA_3_2_2"><span style="color:#000000;font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;line-height:1.28;text-align:left;">Other non-current assets</span></span></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;"></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4.8</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;"></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 8.2</p></td></tr><tr><td style="vertical-align:bottom;width:32.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Current lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:32.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Tc_YJXN6C5RDUaQMlIzxrsjUA_4_2"><span style="-sec-ix-hidden:Tc_YJXN6C5RDUaQMlIzxrsjUA_4_2_2"><span style="color:#000000;font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;line-height:1.28;text-align:left;">Other current liabilities</span></span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1.8</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4.1</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:32.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Non-current lease liabilities</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:32.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Tc_6HCyBN6FqUmtqhou7G1xnA_5_2"><span style="-sec-ix-hidden:Tc_6HCyBN6FqUmtqhou7G1xnA_5_2_2"><span style="color:#000000;font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;line-height:1.28;text-align:left;">Other non-current liabilities</span></span></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;"></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;"></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3.0</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;"></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4.1</p></td></tr><tr><td style="vertical-align:bottom;width:32.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 12pt;"><span style="-sec-ix-hidden:Tc_T-Oesr7Am0SYr9YEBrIrCQ_6_0"><span style="-sec-ix-hidden:Tc_T-Oesr7Am0SYr9YEBrIrCQ_6_0_2"><span style="color:#000000;font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;line-height:1.28;text-align:left;">Total operating lease liabilities</span></span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:32.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4.8</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 8.2</p></td></tr></table><p style="font-family:'Times New Roman';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;line-height:1.28;visibility:hidden;"></span></p><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;text-indent:18pt;margin:6pt 0pt 6pt 0pt;">In connection with completion of construction in the third quarter of 2019 of a building we own, we leased part of the space in the building to another entity as part of a broader collaboration. The lease is accounted for as a sales-type lease. In 2019, we reclassified $23.7 million of property, plant and equipment, net to other non-current assets on our consolidated balance sheets. Our activities under the broader collaboration were immaterial for the year ended December 31, 2019.</p><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;">3. Recently Issued Accounting Standards (Continued)</b></p><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;text-indent:18pt;margin:0pt 0pt 6pt 0pt;">In February 2018, the FASB issued ASU No. 2018-02, <i style="font-style:italic;">Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income</i> (ASU 2018-02). The standard provides financial statement preparers with an option to reclassify stranded tax effects within accumulated other comprehensive income to retained earnings in each period in which the effect (or portion thereof) of the change in the U.S. federal corporate income tax rate under the Tax Cuts and Jobs Act (Tax Reform) is recorded. We adopted the new standard on January 1, 2019. Adoption of this standard did not have a material impact on our financial statements.</p><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;text-indent:18pt;margin:0pt 0pt 6pt 0pt;">In August 2018, the SEC adopted the final rule under SEC Release No. 33-10532, Disclosure Update and Simplification, to eliminate or modify certain disclosure rules that are redundant, outdated, or duplicative of U.S. GAAP or other regulatory requirements. Among other changes, the amendments eliminated the annual requirement to disclose the high and low trading prices of our common stock. In addition, the amendments expanded the disclosure requirements related to the analysis of shareholders’ equity for interim financial statements. An analysis of the changes in each caption of shareholders’ equity presented in the balance sheet must be provided in a note or separate statement, and we provided this disclosure in a separate statement (Consolidated Statements of Stockholders’ Equity) beginning in the first quarter of 2019.</p><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In May 2014, the Financial Accounting Standards Board (FASB) issued ASU No. 2014-09, <i style="font-style:italic;">Revenue from Contracts with Customers (Topic 606)</i> (ASU 2014-09). The new standard supersedes the revenue recognition requirements in Topic 605, <i style="font-style:italic;">Revenue Recognition (Topic 605)</i>, and requires entities to recognize revenue when control of the promised goods or services is transferred to customers. Revenue is recognized in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. We adopted the new standard on January 1, 2018, using the modified retrospective approach, applied only to contracts in effect as of January 1, 2018. Upon adoption, we changed the timing of revenue recognition for sales of Adcirca to recognize revenue when control of Adcirca is transferred to a distributor, which occurs at the time Adcirca is shipped from a Lilly distribution center. Previously, we recognized sales of Adcirca when Adcirca was delivered to distributors. This change did not result in an adjustment to amounts previously recognized as revenue under Topic 605 as all shipments had reached the distributor as of December 31, 2017. Overall, adoption of the new standard did not have a material impact on the amounts reported in our financial statements and there were no other significant changes impacting the timing or measurement of our revenue or our business processes and controls. We have included additional disclosures related to our adoption of Topic 606 in Note 2—<i style="font-style:italic;">Summary of Significant Accounting Policies</i>—<i style="font-style:italic;">Revenue Recognition</i>.</p><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;text-indent:18pt;margin:0pt 0pt 6pt 0pt;"><i style="font-style:italic;">Accounting Standards Not Yet Adopted</i></p><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;text-indent:18pt;margin:0pt 0pt 6pt 0pt;">In June 2016, the FASB issued ASU No. 2016-13, <i style="font-style:italic;">Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</i> (ASU 2016-13), which introduces new guidance for estimating credit losses on certain types of financial instruments based on expected losses and the timing of the recognition of such losses. ASU 2016-13 will be effective for interim and annual reporting periods beginning after December 15, 2019. We identified all of our financial instruments that could be impacted by the new standard as well as gathered data required to comply with the guidance. We updated our internal controls, business processes, and accounting policies related to both the implementation of, and ongoing compliance with, the new guidance. Although we are still finalizing our evaluation of the standard update and the quantification of its impact, we do not expect its adoption will have a material impact.</p><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;">3. Recently Issued Accounting Standards (Continued)</b></p><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;text-indent:18pt;margin:0pt 0pt 6pt 0pt;">In January 2017, the FASB issued ASU No. 2017-04, <i style="font-style:italic;">Intangibles-Goodwill and Other: Simplifying the Test for Goodwill Impairment</i> (ASU 2017-04), which simplifies how an entity is required to test goodwill for impairment. A goodwill impairment will be measured by the amount by which a reporting unit’s carrying value exceeds its fair value, with the amount of impairment not to exceed the carrying amount of goodwill. ASU 2017-04 is effective for goodwill impairment tests in fiscal years beginning after December 15, 2019, and for interim periods within those fiscal years, and must be adopted on a prospective basis. Early adoption is permitted. We do not expect the adoption of this guidance to have a material impact on our financial statements.</p><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;text-indent:18pt;margin:0pt 0pt 6pt 0pt;">In August 2018, the FASB issued ASU No. 2018-13, <i style="font-style:italic;">Fair Value Measurement (Topic 820): Disclosure Framework-Changes to the Disclosure Requirements for Fair Value Measurement</i> (ASU 2018-13), which eliminates, adds and modifies certain disclosure requirements for fair value measurements. ASU 2018-13 is effective for interim and annual reporting periods beginning after December 15, 2019. Early adoption is permitted. We do not expect the adoption of this guidance to have a material impact on our financial statements.</p><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;text-indent:18pt;margin:0pt 0pt 6pt 0pt;">In August 2018, the FASB issued ASU No. 2018-14, <i style="font-style:italic;">Compensation-Retirement Benefits-Defined Benefit Plans-General (Topic 715-20): Disclosure Framework-Changes to the Disclosure Requirements for Defined Benefit Plans</i> (ASU 2018-14). The standard modifies the disclosure requirements for employers that sponsor defined benefit pension or other postretirement plans. ASU 2018-14 is effective for fiscal years beginning after December 15, 2020. Early adoption is permitted. We do not expect the adoption of this guidance to have a material impact on our financial statements.</p><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In December 2019, the FASB issued ASU 2019-12, <i style="font-style:italic;">Simplifying the Accounting for Income Taxes </i>(ASU 2019-12)<i style="font-style:italic;">,</i> which simplifies the accounting for income taxes by removing certain exceptions to the general principles of Topic 740, Income Taxes and also improves consistent application by clarifying and amending existing guidance. ASU 2019-12 is effective for fiscal years beginning after December 15, 2020, with early adoption permitted. We are currently evaluating the impact of this guidance on our financial statements.</p><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.28;margin:0pt 0pt 6pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;"></span></p>
CY2019Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	8200000
CY2019Q3	us-gaap	Temporary Equity Aggregate Amount Of Redemption Requirement TemporaryEquityAggregateAmountOfRedemptionRequirement	8400000
CY2019Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	4600000
CY2019Q4	us-gaap	Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue	684500000
CY2019Q4	uthr	Available For Sale Securities Debt Maturities Rolling Year One Through Three Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesRollingYearOneThroughThreeAmortizedCostBasis	764300000
CY2019Q4	uthr	Number Of Equity Incentive Plans NumberOfEquityIncentivePlans	2
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4800000
CY2019Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	8200000
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1800000
CY2019Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	4100000
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3000000.0
CY2019Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4100000
CY2019Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	4800000
CY2019Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	8200000
CY2018Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	700000
CY2018Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	4200000
CY2018Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	1146200000
CY2018Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	1146200000
CY2019Q4	us-gaap	Available For Sale Securities Debt Maturities Next Rolling Twelve Months Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis	683300000
CY2019Q4	uthr	Available For Sale Securities Debt Maturities Rolling Year One Through Year Three Fair Value AvailableForSaleSecuritiesDebtMaturitiesRollingYearOneThroughYearThreeFairValue	767500000
CY2019Q4	uthr	Contractual Maturities Of Available For Sale Debt Securities Amortized Cost Basis ContractualMaturitiesOfAvailableForSaleDebtSecuritiesAmortizedCostBasis	1447600000
CY2019Q4	uthr	Contractual Maturities Of Available For Sale Securities Debt Securities ContractualMaturitiesOfAvailableForSaleSecuritiesDebtSecurities	1452000000.0
CY2019Q4	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	0
CY2018Q4	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	39600000
CY2019	us-gaap	Variable Interest Entity Activity Between Vie And Entity Income Or Loss Before Tax VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax	57600000
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	45400000
CY2018	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	-26400000
CY2019Q4	uthr	Accrued Sales Related Royalties Rebates And Fees Current AccruedSalesRelatedRoyaltiesRebatesAndFeesCurrent	71500000
CY2018Q4	uthr	Accrued Sales Related Royalties Rebates And Fees Current AccruedSalesRelatedRoyaltiesRebatesAndFeesCurrent	81000000.0
CY2019Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	43400000
CY2018Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	37900000
CY2019Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	23600000
CY2018Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	24100000
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	138500000
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	143000000.0
CY2019Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	148400000
CY2018Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	166100000
CY2018	us-gaap	Income Tax Reconciliation Deductions Extraterritorial Income Exclusion IncomeTaxReconciliationDeductionsExtraterritorialIncomeExclusion	3300000
CY2018Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	19200000
CY2019Q2	uthr	Temporary Equity Amount Of Common Stock Subject To Repurchase TemporaryEquityAmountOfCommonStockSubjectToRepurchase	10800000
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	9900000
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	23100000
CY2017	us-gaap	Interest Expense Other InterestExpenseOther	1900000
CY2019	us-gaap	Interest Expense InterestExpense	44200000
CY2018	us-gaap	Interest Expense InterestExpense	13900000
CY2017	us-gaap	Interest Expense InterestExpense	9000000.0
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7200000
CY2017	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	73500000
CY2018	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4700000
CY2017	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3300000
CY2017	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	23900000
CY2019	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	700000
CY2018	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	700000
CY2017	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	400000
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-104500000
CY2018	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	589200000
CY2017	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	417900000
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43800000
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43500000
CY2017	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	44000000.0
CY2017	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	100000
CY2018	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	500000
CY2017	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	800000
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43800000
CY2018	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	44000000.0
CY2017	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	44900000
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.39
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	13.54
CY2017	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	9.50
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.39
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	13.39
CY2017	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	9.31
CY2017Q2	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	250000000.0
CY2008Q2	uthr	Class Of Warrant Or Right Purchase Price Of Right Before Amendment And Restatement ClassOfWarrantOrRightPurchasePriceOfRightBeforeAmendmentAndRestatement	64.75
CY2008Q2	uthr	Class Of Warrant Or Right Purchase Price Of Right After Amendment And Restatement ClassOfWarrantOrRightPurchasePriceOfRightAfterAmendmentAndRestatement	400.00
CY2008Q2	uthr	Class Of Warrant Or Right Condition On Exercise Of Rights Minimum Percentage Of Common Stock To Be Acquired In Tender Offer ClassOfWarrantOrRightConditionOnExerciseOfRightsMinimumPercentageOfCommonStockToBeAcquiredInTenderOffer	0.15
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	63100000
CY2018	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	136600000
CY2017	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	261300000
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	9400000
CY2018	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	17400000
CY2019	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	20400000
CY2018	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	14900000
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	72500000
CY2018	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	154000000.0
CY2017	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	15100000
CY2019	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	6300000
CY2018	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	2100000
CY2017	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	1800000
CY2017	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	285200000
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-120100000
CY2018	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	12700000
CY2017	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	67200000
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-12900000
CY2018	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	3000000.0
CY2017	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-800000
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-133000000.0
CY2018	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	15700000
CY2017	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	66400000
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-60500000
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	169700000
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	351600000
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2017	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2019	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-34700000
CY2018	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	159400000
CY2017	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	269200000
CY2019	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-5700000
CY2018	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	11200000
CY2017	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	17500000
CY2019	us-gaap	Income Tax Reconciliation Tax Credits Foreign IncomeTaxReconciliationTaxCreditsForeign	5100000
CY2019	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-4000000.0
CY2018	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	15300000
CY2017	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	14200000
CY2019	us-gaap	Income Tax Reconciliation Deductions Extraterritorial Income Exclusion IncomeTaxReconciliationDeductionsExtraterritorialIncomeExclusion	3300000
CY2019	uthr	Effective Income Tax Rate Reconciliation Deconsolidation Of Vie EffectiveIncomeTaxRateReconciliationDeconsolidationOfVie	1900000
CY2019	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	-1600000
CY2018	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	3600000
CY2017	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	1300000
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	-300000
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	-1900000
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	-4500000
CY2018	us-gaap	Tax Cuts And Jobs Act Of2017 Income Tax Expense Benefit TaxCutsAndJobsActOf2017IncomeTaxExpenseBenefit	-1800000
CY2017	us-gaap	Tax Cuts And Jobs Act Of2017 Income Tax Expense Benefit TaxCutsAndJobsActOf2017IncomeTaxExpenseBenefit	71000000.0
CY2017	us-gaap	Income Tax Reconciliation Deductions IncomeTaxReconciliationDeductions	22800000
CY2017	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	19000000.0
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-60500000
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	169700000
CY2018Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	34300000
CY2018Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.42
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	351600000
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	6500000
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	9300000
CY2019Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	400000
CY2019Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	600000
CY2019Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	14600000
CY2019	uthr	Deferredtaxliabilitiesundistributedforeignentityearnings Deferredtaxliabilitiesundistributedforeignentityearnings	-600000
CY2018	uthr	Deferredtaxliabilitiesundistributedforeignentityearnings Deferredtaxliabilitiesundistributedforeignentityearnings	24800000
CY2019Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	6700000
CY2019Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	5400000
CY2018Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	8300000
CY2018	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	4200000
CY2017	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	4800000
CY2019Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	192400000
CY2018Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	36500000
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	56000000.0
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	57000000.0
CY2019Q4	uthr	Deferred Tax Assets Impairment DeferredTaxAssetsImpairment	25800000
CY2018Q4	uthr	Deferred Tax Assets Impairment DeferredTaxAssetsImpairment	23100000
CY2019Q4	uthr	Deferred Tax Assets Supplemental Executive Retirement Plan DeferredTaxAssetsSupplementalExecutiveRetirementPlan	10100000
CY2018Q4	uthr	Deferred Tax Assets Supplemental Executive Retirement Plan DeferredTaxAssetsSupplementalExecutiveRetirementPlan	10700000
CY2018Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	20700000
CY2019Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	312100000
CY2018Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	191600000
CY2019Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	40700000
CY2018Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	20200000
CY2019Q4	uthr	Deferred Tax Assets Net Before Valuation Allowance DeferredTaxAssetsNetBeforeValuationAllowance	266600000
CY2018Q4	uthr	Deferred Tax Assets Net Before Valuation Allowance DeferredTaxAssetsNetBeforeValuationAllowance	138300000
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	36600000
CY2018Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	42600000
CY2019Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	230000000.0
CY2018Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	95700000
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	500000
CY2018Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	300000
CY2019	uthr	Period For Retire Eligible Participants For Benefits Payments PeriodForRetireEligibleParticipantsForBenefitsPayments	P1Y
CY2019	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2018Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	61700000
CY2018Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	53200000
CY2018Q4	us-gaap	Gross Profit GrossProfit	349500000
CY2019Q4	us-gaap	Defined Benefit Plan Expected Amortization Of Prior Service Cost Credit Next Fiscal Year DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear	1300000
CY2019	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	0.40
CY2019	uthr	Defined Contribution Plan Vesting Of Matching Contribution Service Period DefinedContributionPlanVestingOfMatchingContributionServicePeriod	P3Y
CY2019	uthr	Defined Contribution Plan Annual Increments Vesting Period DefinedContributionPlanAnnualIncrementsVestingPeriod	P3Y
CY2019Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	2100000
CY2019Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	1700000
CY2019Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	1000000.0
CY2019Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	700000
CY2018Q3	us-gaap	Gross Profit GrossProfit	360800000
CY2018Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.98
CY2019Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	6500000
CY2019	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	4900000
CY2018Q2	us-gaap	Gross Profit GrossProfit	382800000
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1448800000
CY2019	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	117600000
CY2019	uthr	Gross Profit Excluding Other Revenue GrossProfitExcludingOtherRevenue	1331200000
CY2019Q4	us-gaap	Gross Profit GrossProfit	282300000
CY2017	us-gaap	Revenues Revenues	1725300000
CY2019Q3	us-gaap	Gross Profit GrossProfit	368500000
CY2019Q2	us-gaap	Gross Profit GrossProfit	346900000
CY2018	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1627800000
CY2018	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	198700000
CY2018	uthr	Gross Profit Excluding Other Revenue GrossProfitExcludingOtherRevenue	1429100000
CY2017	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1725300000
CY2017	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	105700000
CY2017	uthr	Gross Profit Excluding Other Revenue GrossProfitExcludingOtherRevenue	1619600000
CY2019	us-gaap	Revenues Revenues	1448800000
CY2018	us-gaap	Revenues Revenues	1627800000
CY2019	uthr	Number Of Distributors NumberOfDistributors	2
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	738500000
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	699700000
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	545700000
CY2019Q4	us-gaap	Revenues Revenues	311100000
CY2019Q3	us-gaap	Revenues Revenues	401500000
CY2019Q2	us-gaap	Revenues Revenues	373600000
CY2019Q1	us-gaap	Revenues Revenues	362600000
CY2019Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	28800000
CY2019Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	33000000.0
CY2019Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	26700000
CY2019Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	29100000
CY2018Q1	us-gaap	Gross Profit GrossProfit	336000000.0
CY2018Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	65300000
CY2019Q1	us-gaap	Gross Profit GrossProfit	333500000
CY2019Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	52600000
CY2018Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	31900000
CY2018Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	51900000
CY2018Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	106500000
CY2018Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	172900000
CY2018Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	244500000
CY2018Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.50
CY2018Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.44
CY2018Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.01
CY2018Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	5.65
CY2018Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.48
CY2019Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	132400000
CY2019Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	205100000
CY2019Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-494600000
CY2019Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.20
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.02
CY2019Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.68
CY2019Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-11.32
CY2019Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.20
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.01
CY2019Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.66
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-11.32
CY2018Q4	us-gaap	Revenues Revenues	381400000
CY2018Q3	us-gaap	Revenues Revenues	412700000
CY2018Q2	us-gaap	Revenues Revenues	444500000
CY2018Q1	us-gaap	Revenues Revenues	389200000
CY2018Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	5.57
CY2019Q1	uthr	Upfront Payment UpfrontPayment	800000000.0

Files In Submission

Name	View Source	Status
0001104659-20-025009-index-headers.html	Edgar Link	pending
0001104659-20-025009-index.html	Edgar Link	pending
0001104659-20-025009.txt	Edgar Link	pending
0001104659-20-025009-xbrl.zip	Edgar Link	pending
ex-10d52.htm	Edgar Link	pending
ex-10d59.htm	Edgar Link	pending
ex-21.htm	Edgar Link	pending
ex-23d1.htm	Edgar Link	pending
ex-31d1.htm	Edgar Link	pending
ex-31d2.htm	Edgar Link	pending
ex-32d1.htm	Edgar Link	pending
ex-32d2.htm	Edgar Link	pending
ex-4d2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
uthr-20191231.xsd	Edgar Link	pending
uthr-20191231x10k0be536.htm	Edgar Link	pending
uthr-20191231x10k0be536003.jpg	Edgar Link	pending
uthr-20191231x10k0be536_htm.xml	Edgar Link	completed
uthr-20191231_cal.xml	Edgar Link	unprocessable
uthr-20191231_def.xml	Edgar Link	unprocessable
uthr-20191231_lab.xml	Edgar Link	unprocessable
uthr-20191231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$UTHR
UNITED THERAPEUTICS Corp Stock $uthr

2019 Q4 Form 10-K Financial Statement

#000110465920025009 Filed on February 26, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$UTHR UNITED THERAPEUTICS Corp Stock $uthr

2019 Q4 Form 10-K Financial Statement

#000110465920025009 Filed on February 26, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$UTHR
UNITED THERAPEUTICS Corp Stock $uthr